ISRG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Intuitive Surgical Inc (ISRG) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows solid financial performance and growth potential, the technical indicators suggest a bearish trend, and insider selling activity raises concerns. Additionally, the absence of strong proprietary trading signals and mixed analyst ratings further support a hold recommendation.
The technical indicators show a bearish trend with moving averages (SMA_200 > SMA_20 > SMA_5). The RSI is neutral at 45.361, and the MACD is above 0 but positively contracting. The stock is trading near its pivot level of 459.857, with support at 449.843 and resistance at 469.871.
The da Vinci robotic surgery system holds a 60% market share and is poised for growth due to an aging population and international market expansion.
Strong financial performance in Q4 2025 with revenue up 18.76% YoY and EPS up 17.55% YoY.
Analysts highlight elevated procedure growth and a new product cycle as potential revenue and EPS growth drivers.
Insider selling has increased by 184% over the last month, which could indicate a lack of confidence from management.
Analysts have recently lowered price targets, reflecting cautious sentiment ahead of Q1 earnings.
The stock has a 20% chance of declining by -10.11% in the next month based on candlestick pattern analysis.
In Q4 2025, the company reported revenue of $2.87 billion, up 18.76% YoY, and net income of $794.8 million, up 15.91% YoY. EPS increased to 2.21, up 17.55% YoY. However, gross margin dropped to 66.44%, down -2.35% YoY.
Analyst ratings are mixed. While some firms like Citi and TD Cowen have Buy ratings with high price targets ($590 and $660, respectively), others like Mizuho and UBS maintain Neutral ratings with lower targets. Recent price target reductions indicate cautious sentiment ahead of Q1 earnings.
